| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of canonical Wnt signaling pathway | AMER1 HECW1 CTDNEP1 SOX13 CCDC88C ZNRF3 CSNK1G1 DACT3 CTNND2 WNK2 | 6.13e-06 | 285 | 119 | 10 | GO:0060828 |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | AMER1 HECW1 CTDNEP1 SOX13 CCDC88C ZNRF3 CSNK1G1 DACT3 CTNND2 WNK2 | 3.11e-05 | 344 | 119 | 10 | GO:0060070 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | ARHGEF5 PPFIA1 PLEKHG2 SHANK3 CCDC88C MAP1S MEGF9 KANK3 SORBS3 TNXB VASP | 4.71e-05 | 438 | 119 | 11 | GO:1902903 |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | AMER1 HECW1 CTDNEP1 SOX13 CCDC88C ZNRF3 CSNK1G1 DACT3 CTNND2 WNK2 | 5.49e-05 | 368 | 119 | 10 | GO:0030111 |
| GeneOntologyBiologicalProcess | actin filament-based process | ARHGEF5 PPFIA1 SH3KBP1 PLEKHG2 ECT2 SPECC1 SHANK3 CCDC88C LLGL2 MEGF9 KANK3 SORBS3 CACNA1H TNXB VASP KLHL17 | 7.04e-05 | 912 | 119 | 16 | GO:0030029 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | ARHGEF5 PPFIA1 PARP3 PLEKHG2 ECT2 SHANK3 CCDC88C MAP1S MEGF9 KANK3 SORBS3 VASP | 1.32e-04 | 579 | 119 | 12 | GO:0051493 |
| Domain | SH3_2 | 1.74e-05 | 86 | 118 | 6 | PF07653 | |
| Domain | SH3_2 | 1.74e-05 | 86 | 118 | 6 | IPR011511 | |
| Domain | HECW_N | 3.96e-05 | 2 | 118 | 2 | IPR032348 | |
| Domain | HECW_N | 3.96e-05 | 2 | 118 | 2 | PF16562 | |
| Domain | - | 1.89e-04 | 391 | 118 | 10 | 2.30.29.30 | |
| Domain | WW | 2.19e-04 | 47 | 118 | 4 | PF00397 | |
| Domain | FAM47 | 2.36e-04 | 4 | 118 | 2 | PF14642 | |
| Domain | Tensin_PTB | 2.36e-04 | 4 | 118 | 2 | IPR033929 | |
| Domain | FAM47 | 2.36e-04 | 4 | 118 | 2 | IPR032743 | |
| Domain | WW | 2.38e-04 | 48 | 118 | 4 | SM00456 | |
| Domain | WW_DOMAIN_1 | 3.01e-04 | 51 | 118 | 4 | PS01159 | |
| Domain | WW_DOMAIN_2 | 3.01e-04 | 51 | 118 | 4 | PS50020 | |
| Domain | WW_dom | 3.24e-04 | 52 | 118 | 4 | IPR001202 | |
| Domain | PH_dom-like | 3.73e-04 | 426 | 118 | 10 | IPR011993 | |
| Domain | SANT_dom | 5.75e-04 | 26 | 118 | 3 | IPR017884 | |
| Domain | SANT | 7.18e-04 | 28 | 118 | 3 | PS51293 | |
| Domain | PKD | 8.14e-04 | 7 | 118 | 2 | PF00801 | |
| Domain | PTEN_C2 | 1.08e-03 | 8 | 118 | 2 | PF10409 | |
| Domain | PTB | 1.08e-03 | 8 | 118 | 2 | IPR013625 | |
| Domain | PTEN_C2 | 1.08e-03 | 8 | 118 | 2 | SM01326 | |
| Domain | PTB | 1.08e-03 | 8 | 118 | 2 | PF08416 | |
| Domain | C2_TENSIN | 1.08e-03 | 8 | 118 | 2 | PS51182 | |
| Domain | Tensin_lipid_phosphatase_dom | 1.08e-03 | 8 | 118 | 2 | IPR029023 | |
| Domain | Tensin_C2-dom | 1.08e-03 | 8 | 118 | 2 | IPR014020 | |
| Domain | PPASE_TENSIN | 1.38e-03 | 9 | 118 | 2 | PS51181 | |
| Domain | PKD/Chitinase_dom | 1.38e-03 | 9 | 118 | 2 | IPR022409 | |
| Domain | PKD | 1.38e-03 | 9 | 118 | 2 | SM00089 | |
| Domain | VDCCAlpha1 | 1.72e-03 | 10 | 118 | 2 | IPR002077 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TMEM8B NLRX1 ZBTB4 PAPLN PPP6R1 PIGG MAST2 CTDNEP1 ZDHHC8 RASSF7 BAHD1 CCDC88C NCOR2 LLGL2 SLC2A4RG MAP1S SBF1 NFATC1 ZNRF3 KANK3 SORBS3 CACNA1H ATG9A CRAMP1 WNK2 PCNT KLHL17 | 1.99e-15 | 1105 | 124 | 27 | 35748872 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | SDK2 AMER1 PKD1L1 BAG3 MAST2 ECT2 MAP1S NSUN5P2 MTCL1 CTNND2 SRRM2 PRRC2A CPSF7 | 6.37e-10 | 361 | 124 | 13 | 26167880 |
| Pubmed | CACNA1A MIA3 HECW1 PPFIA1 SH3KBP1 PPP6R1 ARHGAP39 SHANK3 LUZP1 CCDC88C NCOR2 SBF1 MTCL1 CTNND2 TNS1 PRRC2A WNK2 PCNT | 1.02e-08 | 963 | 124 | 18 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MIIP AMER1 ARHGEF5 PPFIA1 BAG3 PLEKHG2 MAST2 ECT2 SPECC1 RASSF7 LUZP1 PIK3R4 USP31 CCDC88C SBF1 MTCL1 SRRM2 | 1.23e-08 | 861 | 124 | 17 | 36931259 |
| Pubmed | MIA3 PPFIA1 BAG3 TNS2 PPP6R1 ARHGAP39 CTDNEP1 LUZP1 USP31 NCOR2 SBF1 DDX54 SORBS3 SRRM2 TNS1 PRRC2A CBX8 PCNT | 3.74e-08 | 1049 | 124 | 18 | 27880917 | |
| Pubmed | 1.69e-07 | 233 | 124 | 9 | 37704626 | ||
| Pubmed | CACNA1A SH3KBP1 BCAN ARHGAP39 PLEKHA6 SPECC1 ADCY5 CTNND2 SRRM2 PRRC2A | 5.12e-07 | 347 | 124 | 10 | 17114649 | |
| Pubmed | CACNA1A PPFIA1 SH3KBP1 BCAN ARHGAP39 PLEKHA6 SPECC1 SHANK3 LUZP1 PIK3R4 USP31 MAP1S SBF1 HECW2 CTNND2 TNS1 PRRC2A WNK2 CPSF7 | 7.85e-07 | 1431 | 124 | 19 | 37142655 | |
| Pubmed | Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals. | 1.25e-05 | 142 | 124 | 6 | 19851296 | |
| Pubmed | Tensin1 and a previously undocumented family member, tensin2, positively regulate cell migration. | 1.26e-05 | 2 | 124 | 2 | 11792844 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 33989081 | ||
| Pubmed | Association study between the TNXB locus and schizophrenia in a Japanese population. | 1.26e-05 | 2 | 124 | 2 | 17192952 | |
| Pubmed | 2'-Hydroxycinnamaldehyde induces apoptosis through HSF1-mediated BAG3 expression. | 1.26e-05 | 2 | 124 | 2 | 27922674 | |
| Pubmed | BAG3 affects the nucleocytoplasmic shuttling of HSF1 upon heat stress. | 1.26e-05 | 2 | 124 | 2 | 26159920 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18286539 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 29513218 | ||
| Pubmed | Association of genetic variants with hemorrhagic stroke in Japanese individuals. | 1.30e-05 | 143 | 124 | 6 | 20198315 | |
| Pubmed | 1.71e-05 | 225 | 124 | 7 | 12168954 | ||
| Pubmed | 2.11e-05 | 529 | 124 | 10 | 14621295 | ||
| Pubmed | 3.34e-05 | 446 | 124 | 9 | 24255178 | ||
| Pubmed | 3.47e-05 | 18 | 124 | 3 | 19143821 | ||
| Pubmed | 3.47e-05 | 18 | 124 | 3 | 19116923 | ||
| Pubmed | Dual function of cTAGE5 in collagen export from the endoplasmic reticulum. | 3.77e-05 | 3 | 124 | 2 | 27170179 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 27138255 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 26216687 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 27413011 | ||
| Pubmed | Promyogenic function of Integrin/FAK signaling is mediated by Cdo, Cdc42 and MyoD. | 3.77e-05 | 3 | 124 | 2 | 21397010 | |
| Pubmed | BAG3 regulates contractility and Ca(2+) homeostasis in adult mouse ventricular myocytes. | 3.77e-05 | 3 | 124 | 2 | 26796036 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 10406466 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 29581247 | ||
| Pubmed | 4.56e-05 | 55 | 124 | 4 | 14656967 | ||
| Pubmed | 5.61e-05 | 21 | 124 | 3 | 21408207 | ||
| Pubmed | 6.48e-05 | 22 | 124 | 3 | 12812986 | ||
| Pubmed | 6.74e-05 | 118 | 124 | 5 | 30979931 | ||
| Pubmed | HECW1 RTEL1 ZBTB4 ZFP28 ARHGAP39 PLEKHA6 SHANK3 CCDC88C UNC80 | 7.22e-05 | 493 | 124 | 9 | 15368895 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 31800012 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 19194507 | ||
| Pubmed | Foxc2 induces expression of MyoD and differentiation of the mouse myoblast cell line C2C12. | 7.53e-05 | 4 | 124 | 2 | 17506979 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 21525241 | ||
| Pubmed | Concentration of Sec12 at ER exit sites via interaction with cTAGE5 is required for collagen export. | 7.53e-05 | 4 | 124 | 2 | 25202031 | |
| Pubmed | TANGO1/cTAGE5 receptor as a polyvalent template for assembly of large COPII coats. | 7.53e-05 | 4 | 124 | 2 | 27551091 | |
| Pubmed | Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature. | 7.53e-05 | 4 | 124 | 2 | 21788606 | |
| Pubmed | Role of the Rho GTPase-activating protein RICS in neurite outgrowth. | 7.53e-05 | 4 | 124 | 2 | 16716191 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 17111365 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 37937642 | ||
| Pubmed | 7.85e-05 | 197 | 124 | 6 | 36604605 | ||
| Pubmed | 8.30e-05 | 199 | 124 | 6 | 36688959 | ||
| Pubmed | 1.02e-04 | 402 | 124 | 8 | 24722188 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.07e-04 | 130 | 124 | 5 | 35545047 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | BAG3 PHRF1 ARHGAP39 HEXIM2 PASK NCOR2 MAP1S SORBS3 HSF1 SRRM2 PRRC2A | 1.07e-04 | 774 | 124 | 11 | 15302935 |
| Pubmed | 1.09e-04 | 209 | 124 | 6 | 36779422 | ||
| Pubmed | 1.22e-04 | 27 | 124 | 3 | 19026994 | ||
| Pubmed | 1.25e-04 | 5 | 124 | 2 | 14684739 | ||
| Pubmed | 1.25e-04 | 5 | 124 | 2 | 17190795 | ||
| Pubmed | Characterization and expression pattern of the novel MIA homolog TANGO. | 1.25e-04 | 5 | 124 | 2 | 15183315 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.62e-04 | 430 | 124 | 8 | 35044719 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | CACNA1A PPFIA1 PARP3 MUC16 PLEKHA6 CSNK1G2-AS1 TNS1 TNXB UNC80 | 1.69e-04 | 552 | 124 | 9 | 10737800 |
| Pubmed | STK40 Is a Pseudokinase that Binds the E3 Ubiquitin Ligase COP1. | 1.85e-04 | 31 | 124 | 3 | 28089446 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.87e-04 | 231 | 124 | 6 | 16452087 | |
| Pubmed | TANGO1 recruits Sec16 to coordinately organize ER exit sites for efficient secretion. | 1.87e-04 | 6 | 124 | 2 | 28442536 | |
| Pubmed | The sinus venosus contributes to coronary vasculature through VEGFC-stimulated angiogenesis. | 1.87e-04 | 6 | 124 | 2 | 25377552 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 1.91e-04 | 232 | 124 | 6 | 25515538 | |
| Pubmed | TMEM8B COX11 SEZ6L2 CCDC88C PASK KANK3 B3GAT1 CACNA1H CTNND2 | 2.09e-04 | 568 | 124 | 9 | 9110174 | |
| Pubmed | A "double adaptor" method for improved shotgun library construction. | TMEM8B COX11 SEZ6L2 CCDC88C PASK KANK3 B3GAT1 CACNA1H CTNND2 | 2.26e-04 | 574 | 124 | 9 | 8619474 |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 2.35e-04 | 154 | 124 | 5 | 16055720 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MIA3 AMER1 PKD1L1 PLEKHG2 MAST2 RASSF7 LUZP1 CCDC88C NFKBIE CBX8 PCNT | 2.48e-04 | 853 | 124 | 11 | 28718761 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 2.50e-04 | 582 | 124 | 9 | 20467437 | |
| Pubmed | CLP-1 associates with MyoD and HDAC to restore skeletal muscle cell regeneration. | 2.62e-04 | 7 | 124 | 2 | 20940258 | |
| Pubmed | ProSAPiP2, a novel postsynaptic density protein that interacts with ProSAP2/Shank3. | 2.62e-04 | 7 | 124 | 2 | 19481056 | |
| Pubmed | 2.62e-04 | 7 | 124 | 2 | 15572127 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MIA3 AMER1 RTEL1 TMEM8B ARHGAP39 HEXIM2 NCOR2 NFATC1 RPRD2 CACNA1H GREB1 RPS6KL1 CRAMP1 WNK2 PCNT | 2.78e-04 | 1489 | 124 | 15 | 28611215 |
| Pubmed | 2.92e-04 | 251 | 124 | 6 | 31076518 | ||
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 2.97e-04 | 162 | 124 | 5 | 31363146 | |
| Pubmed | 3.21e-04 | 360 | 124 | 7 | 33111431 | ||
| Pubmed | Lysine acetylation targets protein complexes and co-regulates major cellular functions. | 3.41e-04 | 38 | 124 | 3 | 19608861 | |
| Pubmed | 3.48e-04 | 8 | 124 | 2 | 15520228 | ||
| Pubmed | Divergent hTAFII31-binding motifs hidden in activation domains. | 3.48e-04 | 8 | 124 | 2 | 10821850 | |
| Pubmed | 3.48e-04 | 8 | 124 | 2 | 22694956 | ||
| Pubmed | Protein phosphatase 6 subunit with conserved Sit4-associated protein domain targets IkappaBepsilon. | 3.48e-04 | 8 | 124 | 2 | 16769727 | |
| Pubmed | 3.48e-04 | 8 | 124 | 2 | 1383086 | ||
| Pubmed | 4.47e-04 | 9 | 124 | 2 | 16382099 | ||
| Pubmed | 4.61e-04 | 503 | 124 | 8 | 16964243 | ||
| Pubmed | 5.18e-04 | 103 | 124 | 4 | 10819331 | ||
| Pubmed | AMER1 BAG3 PPP6R1 PLEKHA6 SPECC1 LUZP1 HEXIM2 NCOR2 DDX54 SRRM2 PRRC2A VASP CPSF7 | 5.26e-04 | 1247 | 124 | 13 | 27684187 | |
| Pubmed | 5.56e-04 | 650 | 124 | 9 | 38777146 | ||
| Pubmed | 5.57e-04 | 10 | 124 | 2 | 20950796 | ||
| Pubmed | Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression. | 5.57e-04 | 10 | 124 | 2 | 15536134 | |
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 6.20e-04 | 108 | 124 | 4 | 19531213 | |
| Pubmed | 6.65e-04 | 407 | 124 | 7 | 12693553 | ||
| Pubmed | NEDL2 is an essential regulator of enteric neural development and GDNF/Ret signaling. | 6.79e-04 | 11 | 124 | 2 | 25555806 | |
| Pubmed | Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors. | 6.79e-04 | 11 | 124 | 2 | 39256359 | |
| Pubmed | Non-apical mitoses contribute to cell delamination during mouse gastrulation. | 6.79e-04 | 11 | 124 | 2 | 39198421 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | SH3KBP1 ZFP28 PPP6R1 ZNF784 MAST2 BAHD1 CCDC88C SBF1 CSNK1G1 ATG9A CTNND2 TNS1 | 7.05e-04 | 1124 | 124 | 12 | 21900206 |
| Pubmed | 7.92e-04 | 201 | 124 | 5 | 23535732 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 7.99e-04 | 420 | 124 | 7 | 28065597 | |
| Pubmed | 8.13e-04 | 12 | 124 | 2 | 28890073 | ||
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | 9.28e-04 | 431 | 124 | 7 | 33660365 | |
| Pubmed | AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair. | 9.48e-04 | 121 | 124 | 4 | 31900314 | |
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 9.59e-04 | 13 | 124 | 2 | 9833687 | |
| Pubmed | Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. | 9.59e-04 | 13 | 124 | 2 | 11839810 | |
| Interaction | TOP3B interactions | RTEL1 TMEM8B NLRX1 ZBTB4 PAPLN PPP6R1 PIGG MAST2 CTDNEP1 ZDHHC8 RASSF7 BAHD1 CCDC88C NCOR2 LLGL2 SLC2A4RG MAP1S SBF1 NFATC1 ZNRF3 KANK3 SORBS3 CACNA1H ATG9A PRRC2A CRAMP1 WNK2 PCNT KLHL17 | 1.24e-08 | 1470 | 123 | 29 | int:TOP3B |
| Interaction | YWHAH interactions | MIIP AMER1 ARHGEF5 PPFIA1 BAG3 TNS2 PLEKHG2 MAST2 ECT2 SPECC1 RASSF7 LUZP1 PIK3R4 USP31 CCDC88C SBF1 MTCL1 ATG9A SRRM2 WNK2 PCNT | 3.08e-06 | 1102 | 123 | 21 | int:YWHAH |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | RASGRP4 ZFP28 PPP6R1 PLEKHG2 ZNF784 BLVRB SSC5D DACT3 CEACAM16 VASP ZNF541 | 4.04e-04 | 1192 | 124 | 11 | chr19q13 |
| Cytoband | 16p13.3 | 5.48e-04 | 244 | 124 | 5 | 16p13.3 | |
| GeneFamily | C2 tensin-type domain containing|PTEN protein phosphatases|Phosphoinositide phosphatases | 1.87e-04 | 5 | 79 | 2 | 902 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 5.19e-04 | 8 | 79 | 2 | 837 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.61e-03 | 53 | 79 | 3 | 532 | |
| GeneFamily | Zinc fingers C2H2-type|Kruppel like factors | 2.76e-03 | 18 | 79 | 2 | 624 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.01e-03 | 66 | 79 | 3 | 722 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | CACNA1A CCDC28B DACH1 PPP6R1 SEZ6L2 SPECC1 ZDHHC8 BAHD1 MEGF9 CACNA1H UNC80 WNK2 | 8.13e-07 | 429 | 122 | 12 | M45694 |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.87e-09 | 187 | 124 | 9 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.01e-09 | 188 | 124 | 9 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.22e-08 | 166 | 124 | 8 | 30a991fc3275b571d53bd0976df4789e5d40b01d | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.22e-08 | 166 | 124 | 8 | 76b4cd32698900797ec009f17e50ea7ae36b85f4 | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-Late_cap|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.73e-08 | 183 | 124 | 8 | 3e69cc605f166a1f04e3d077935f7cfd806f1ffd | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.37e-08 | 186 | 124 | 8 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.36e-08 | 197 | 124 | 8 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | tumor_Lung-Endothelial_cells-Tip-like_ECs|tumor_Lung / Location, Cell class and cell subclass | 8.36e-08 | 197 | 124 | 8 | 353b76ca3e2aa4b8f51396e7121c4baa114083a0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.69e-08 | 198 | 124 | 8 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.21e-07 | 159 | 124 | 7 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.13e-07 | 175 | 124 | 7 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.87e-07 | 178 | 124 | 7 | 360d7a987f91d6d721487a921824057ec31a7332 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.41e-07 | 180 | 124 | 7 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | Endothelial-A-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 7.41e-07 | 180 | 124 | 7 | 4c3376169770ee9f9283daae44c17f35e46bfd19 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.91e-07 | 188 | 124 | 7 | 0026c9479b30fb39daa91cfa220a88f9c9e65fe7 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.91e-07 | 188 | 124 | 7 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 9.91e-07 | 188 | 124 | 7 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.03e-06 | 189 | 124 | 7 | b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-06 | 189 | 124 | 7 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.06e-06 | 190 | 124 | 7 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.10e-06 | 191 | 124 | 7 | 1de0bdfd13bd930691564c2673f2e66393bc0255 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.18e-06 | 193 | 124 | 7 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | (6)_Endothelial-C_(Capillary_Aerocyte_)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.18e-06 | 193 | 124 | 7 | f7f2dc6aff02d096a282835094d26d12b3b73e61 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.22e-06 | 194 | 124 | 7 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-myocytic|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-06 | 196 | 124 | 7 | 20dc9b25ecc23b6e6e52bbab8b5a404f3245ca37 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.35e-06 | 197 | 124 | 7 | 6a3c647af41fea923311562575a0d656fbc13cbe | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-06 | 198 | 124 | 7 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.40e-06 | 198 | 124 | 7 | a75499f8f1630359b64717c300621aa3b1ab44d4 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.40e-06 | 198 | 124 | 7 | 75270600b5b29187dfa86f01f8f927ae0621cda4 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-06 | 199 | 124 | 7 | 7ed541309808f15d65a9c4b26be2050e077539e6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.45e-06 | 199 | 124 | 7 | d95d78b2ebc9a20532466e4d4be579b4faf6776f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.45e-06 | 199 | 124 | 7 | cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-06 | 199 | 124 | 7 | 14a7c4cf4bb3d43fd32ec9cc74f6625b225ffaa1 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.50e-06 | 200 | 124 | 7 | 410b1a31de21c57d87ca2104f61cf4a7d4dd2f30 | |
| ToppCell | distal-Endothelial-Capillary_Intermediate_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.50e-06 | 200 | 124 | 7 | 43bc48413b100a06f8edd9acd812296788fcbf5b | |
| ToppCell | Biopsy_IPF-Endothelial|Biopsy_IPF / Sample group, Lineage and Cell type | 1.50e-06 | 200 | 124 | 7 | 7ccd3b617838b39da814278dc0e12384013401ce | |
| ToppCell | distal-Endothelial-Capillary_Intermediate_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.50e-06 | 200 | 124 | 7 | 4d6714d48738cdee7d535923f6dd2431e5304741 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-06 | 162 | 124 | 6 | c399b9e4854916a59f5cae2d8dbf19660f8759be | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-06 | 162 | 124 | 6 | a291248b693c771845174393934a782f1d8bd7ce | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.43e-06 | 167 | 124 | 6 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.51e-06 | 171 | 124 | 6 | b3e6e31dfe3623b960ccf692fdbd236fa4039923 | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 8.80e-06 | 172 | 124 | 6 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-06 | 173 | 124 | 6 | fc2602b2ce051cd4c33957d7e3d041ff8a529883 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.09e-06 | 173 | 124 | 6 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-06 | 173 | 124 | 6 | 901b8e6909c1f3849906fad9cee17b8f0bab050d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.71e-06 | 175 | 124 | 6 | 90302e8a44858ef3b2a165b88284d4788d591a99 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-05 | 177 | 124 | 6 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-05 | 180 | 124 | 6 | 755050226eeb1991ee7f0d15e39d0458f3e4a791 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-05 | 180 | 124 | 6 | 8ab16a0b9053bffc07b569a4f9e71749f56dde7e | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-05 | 180 | 124 | 6 | 394cd465b88429b70eebb2957480dffcbc51cfe7 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-05 | 181 | 124 | 6 | 9bfd93cf053beaee806cacdffd7abef02f94aec6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-05 | 181 | 124 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 182 | 124 | 6 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.21e-05 | 182 | 124 | 6 | d7cce5dd7046f06bf40f00c9dbfa610722b03333 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-05 | 182 | 124 | 6 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-05 | 183 | 124 | 6 | d67454baf0cf791a743b51afd1cb25bfb5765385 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 183 | 124 | 6 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 183 | 124 | 6 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-05 | 183 | 124 | 6 | e49ac8314b6fe98426b1514ea68d646297b8bc0f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-05 | 184 | 124 | 6 | fa38d6a8709f520a027ad7e3ff783c84187ec467 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.33e-05 | 185 | 124 | 6 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 1.33e-05 | 185 | 124 | 6 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-05 | 186 | 124 | 6 | f0b78c7ee20279970ea8961bf59acb5262f2dce5 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations) | 1.37e-05 | 186 | 124 | 6 | c6075fe84226b370c5139066793844ad33ae2db1 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-05 | 186 | 124 | 6 | 2b3c814a7dee8286ea113c63dc3de5daf0257d37 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells-Tumor_ECs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.41e-05 | 187 | 124 | 6 | be5f8c5802b0fa8cc1e274fdf06b13eb8ceb8ad4 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.46e-05 | 188 | 124 | 6 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 188 | 124 | 6 | 05de6677f9bb4b00fed47f4b72f4a2cd507cb0f2 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 1.46e-05 | 188 | 124 | 6 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.46e-05 | 188 | 124 | 6 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.46e-05 | 188 | 124 | 6 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-05 | 189 | 124 | 6 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-05 | 189 | 124 | 6 | d69b7a01dd4d6ad043bb6210e9ab34b49578389c | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-05 | 189 | 124 | 6 | 9e58411e51019ca59e78d3e737d65d2bcbbea2be | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-05 | 189 | 124 | 6 | 2b5f1b4f173a224342ea4f10b193ee33b7662699 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-05 | 189 | 124 | 6 | 43e131458d8a4b120f7a5fb3d0c5650abded15f6 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 1.55e-05 | 190 | 124 | 6 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.55e-05 | 190 | 124 | 6 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-05 | 190 | 124 | 6 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.55e-05 | 190 | 124 | 6 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.55e-05 | 190 | 124 | 6 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.59e-05 | 191 | 124 | 6 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 1.59e-05 | 191 | 124 | 6 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 192 | 124 | 6 | 8f20d3511dcb44445592b17d005a53da0052ae56 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-05 | 192 | 124 | 6 | 5a0615fdc217554ccd611504b16e5d97628e207d | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.64e-05 | 192 | 124 | 6 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-endothelial_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 192 | 124 | 6 | 0986b7900021efe2a4df84a935e7c9a0af1b0e57 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-05 | 192 | 124 | 6 | 1f35efb0765e05f7f9c881849953bef3965be25a | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 192 | 124 | 6 | b28d294e42b303d1db6060231d84d7b9e4d9fccf | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.69e-05 | 193 | 124 | 6 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 193 | 124 | 6 | e340064cd146deac03f2d0fd43e2e218bb6057c9 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)|Adult / Lineage, Cell type, age group and donor | 1.69e-05 | 193 | 124 | 6 | 39c6c96a2a100b1b290a779d36cc6bc17245720b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-05 | 193 | 124 | 6 | dd443b83d328a9069ffe19ac3d74066e922515a5 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.69e-05 | 193 | 124 | 6 | ff6e6b825d6c88148216c601580be3c28851ab5c | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 193 | 124 | 6 | a211b386fd0fb9da9937361d29d90925a72c9715 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.69e-05 | 193 | 124 | 6 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.69e-05 | 193 | 124 | 6 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | facs-BAT-Fat-3m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 193 | 124 | 6 | 3086c33f4d6fab66966818737f95ae4d6b2615b0 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-05 | 194 | 124 | 6 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.74e-05 | 194 | 124 | 6 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| Drug | Atovaquone [95233-18-4]; Down 200; 11uM; PC3; HT_HG-U133A | 9.88e-06 | 195 | 121 | 8 | 4201_DN | |
| Drug | Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.03e-05 | 196 | 121 | 8 | 3567_DN | |
| Drug | Hesperidin [520-26-3]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.03e-05 | 196 | 121 | 8 | 2648_DN | |
| Drug | Alprostadil [745-65-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.06e-05 | 197 | 121 | 8 | 7358_UP | |
| Drug | pentasulfane | 7.80e-05 | 16 | 121 | 3 | CID000448216 | |
| Drug | SnBu2H2 | 7.80e-05 | 16 | 121 | 3 | CID000006513 | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 7.89e-05 | 193 | 121 | 7 | 4241_DN | |
| Drug | carmustine; Down 200; 100uM; PC3; HT_HG-U133A | 8.15e-05 | 194 | 121 | 7 | 6883_DN | |
| Drug | Imipenem [74431-23-5]; Down 200; 13.4uM; HL60; HG-U133A | 8.15e-05 | 194 | 121 | 7 | 1724_DN | |
| Drug | Pirenperone [ 75444-65-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 8.15e-05 | 194 | 121 | 7 | 3316_DN | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; MCF7; HT_HG-U133A | 8.15e-05 | 194 | 121 | 7 | 7044_UP | |
| Drug | Cefoperazone dihydrate; Down 200; 5.8uM; MCF7; HT_HG-U133A | 8.41e-05 | 195 | 121 | 7 | 5424_DN | |
| Drug | Sulfamerazine [127-79-7]; Down 200; 15.2uM; PC3; HT_HG-U133A | 8.41e-05 | 195 | 121 | 7 | 3718_DN | |
| Drug | Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 8.69e-05 | 196 | 121 | 7 | 3233_DN | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; PC3; HT_HG-U133A | 8.69e-05 | 196 | 121 | 7 | 7317_DN | |
| Drug | Liothyronine [6893-02-3]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 8.69e-05 | 196 | 121 | 7 | 3324_DN | |
| Drug | Probucol [23288-49-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 8.69e-05 | 196 | 121 | 7 | 5261_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; PC3; HT_HG-U133A | 8.69e-05 | 196 | 121 | 7 | 4446_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; PC3; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 4547_DN | |
| Drug | Proxyphylline [603-00-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 5993_DN | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 3846_DN | |
| Drug | Brinzolamide [138890-62-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 3230_DN | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 8.97e-05 | 197 | 121 | 7 | 1012_DN | |
| Drug | Tamoxifen citrate [54965-24-1]; Down 200; 7uM; MCF7; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 6768_DN | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 8.97e-05 | 197 | 121 | 7 | 7171_DN | |
| Drug | Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; PC3; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 4498_DN | |
| Drug | Lactobionic acid [96-82-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 3246_DN | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 2320_DN | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 3175_DN | |
| Drug | vinblastine sulfate; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 7551_DN | |
| Drug | Flumequine [42835-25-6]; Up 200; 15.4uM; PC3; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 5104_UP | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Down 200; 12.2uM; HL60; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 6153_DN | |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 1534_DN | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 6827_DN | |
| Drug | Spironolactone [52-01-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 9.26e-05 | 198 | 121 | 7 | 2226_DN | |
| Drug | Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 9.55e-05 | 199 | 121 | 7 | 4294_DN | |
| Drug | SC-58125; Up 200; 10uM; MCF7; HG-U133A | 9.55e-05 | 199 | 121 | 7 | 254_UP | |
| Drug | Clopamide [636-54-4]; Up 200; 11.6uM; HL60; HG-U133A | 9.55e-05 | 199 | 121 | 7 | 1605_UP | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; PC3; HT_HG-U133A | 9.55e-05 | 199 | 121 | 7 | 7365_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 9.55e-05 | 199 | 121 | 7 | 3759_DN | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; PC3; HT_HG-U133A | 9.55e-05 | 199 | 121 | 7 | 7295_DN | |
| Drug | Atracurium besylate [64228-81-5]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 9.55e-05 | 199 | 121 | 7 | 1702_DN | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | 9.55e-05 | 199 | 121 | 7 | 7254_DN | |
| Drug | Iodipamide [606-17-7]; Down 200; 3.6uM; MCF7; HT_HG-U133A | 9.85e-05 | 200 | 121 | 7 | 5510_DN | |
| Drug | wortmannin; Up 200; 0.01uM; SKMEL5; HG-U133A | 9.85e-05 | 200 | 121 | 7 | 506_UP | |
| Disease | Childhood Absence Epilepsy | 3.46e-04 | 7 | 121 | 2 | C4281785 | |
| Disease | anxiety, smoking behaviour measurement | 3.46e-04 | 7 | 121 | 2 | EFO_0005230, EFO_0005671 | |
| Disease | Epilepsy, Minor | 3.46e-04 | 7 | 121 | 2 | C4552765 | |
| Disease | Absence Epilepsy | 3.46e-04 | 7 | 121 | 2 | C0014553 | |
| Disease | Akinetic Petit Mal | 3.46e-04 | 7 | 121 | 2 | C0001890 | |
| Disease | Epilepsy, Absence, Atypical | 3.46e-04 | 7 | 121 | 2 | C0751124 | |
| Disease | Absence Seizure Disorder | 3.46e-04 | 7 | 121 | 2 | C4553705 | |
| Disease | Juvenile Absence Epilepsy | 3.46e-04 | 7 | 121 | 2 | C4317339 | |
| Disease | cortical surface area measurement | CACNA1A TMEM8B PPFIA1 ARHGAP39 MAST2 KIAA1614 LUZP1 CCDC88C ZNF469 MTCL1 TNS1 PRRC2A TNXB RPS6KL1 WNK2 | 4.09e-04 | 1345 | 121 | 15 | EFO_0010736 |
| Disease | forced expiratory volume | NCOR2 SSC5D LLGL2 SLC2A4RG RPRD2 MTCL1 CTNND2 TNS1 TNXB CBX8 CDON | 4.14e-04 | 789 | 121 | 11 | EFO_0004314 |
| Disease | tauopathy (implicated_via_orthology) | 7.35e-04 | 10 | 121 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | ubiquitin-conjugating enzyme E2 G2 measurement | 7.35e-04 | 10 | 121 | 2 | EFO_0022035 | |
| Disease | factor VIII measurement, coronary artery disease | 1.23e-03 | 113 | 121 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | extracellular matrix protein 1 measurement | 1.26e-03 | 13 | 121 | 2 | EFO_0008126 | |
| Disease | brain connectivity measurement | 1.34e-03 | 400 | 121 | 7 | EFO_0005210 | |
| Disease | IGFBP-3 measurement | 1.43e-03 | 54 | 121 | 3 | EFO_0004626 | |
| Disease | sex interaction measurement, inflammatory bowel disease | 1.51e-03 | 55 | 121 | 3 | EFO_0003767, EFO_0008343 | |
| Disease | endoplasmic reticulum resident protein 29 measurement | 1.93e-03 | 16 | 121 | 2 | EFO_0020346 | |
| Disease | age at diagnosis, type 1 diabetes mellitus | 2.13e-03 | 62 | 121 | 3 | EFO_0004918, MONDO_0005147 | |
| Disease | body fat percentage, type 2 diabetes mellitus | 2.18e-03 | 17 | 121 | 2 | EFO_0007800, MONDO_0005148 | |
| Disease | susceptibility to cold sores measurement | 2.44e-03 | 65 | 121 | 3 | EFO_0008402 | |
| Disease | X-11470 measurement | 2.72e-03 | 19 | 121 | 2 | EFO_0021241 | |
| Disease | anorectal malformation | 2.72e-03 | 19 | 121 | 2 | MONDO_0019938 | |
| Disease | MHC class I polypeptide-related sequence A measurement | 2.78e-03 | 68 | 121 | 3 | EFO_0008233 | |
| Disease | phosphatidylcholine 34:2 measurement | 3.02e-03 | 20 | 121 | 2 | EFO_0010376 | |
| Disease | skin hydration measurement | 3.33e-03 | 21 | 121 | 2 | EFO_0009586 | |
| Disease | migraine disorder | 3.61e-03 | 357 | 121 | 6 | MONDO_0005277 | |
| Disease | prostate carcinoma | RTEL1 MAST2 SOX13 CCDC88C SLC2A4RG B3GAT1 RPS6KL1 CRAMP1 SEC14L5 NOTCH4 | 3.72e-03 | 891 | 121 | 10 | EFO_0001663 |
| Disease | serum non-albumin protein measurement | 3.81e-03 | 361 | 121 | 6 | EFO_0004568 | |
| Disease | reticulocyte count | KLF14 MAST2 SPECC1 SCARF1 BLVRB ZNF469 MEGF9 KLF13 KANK3 TNS1 NOTCH4 | 3.85e-03 | 1045 | 121 | 11 | EFO_0007986 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TRSGGPRGPRHSAPT | 11 | Q6ZR03 | |
| HKDEGSDPRRETPPG | 36 | Q9P2W7 | |
| APPPVRHASSGATGR | 2436 | O00555 | |
| PHRRDSGRPPGDSSG | 1006 | Q12774 | |
| SDSRGPAVEKHPGPS | 1051 | Q12774 | |
| TPGPAHTGREAVRPD | 76 | Q2WEN9 | |
| DSSRLPSEGPRPAHV | 36 | P30043 | |
| SVVLGHGAPRTASPP | 66 | Q8N1L1 | |
| GHGPDRVRPLPAASS | 16 | Q5M775 | |
| RAPGESGPQLARPSH | 1011 | Q5JTC6 | |
| KTAAPAPRGGPEHRS | 16 | O95622 | |
| PSLEEGRRPGSHPSS | 496 | Q9UI36 | |
| TTSRAGHLAGPEPAP | 206 | Q9UQB3 | |
| PPGTPSVDHGFLVTR | 1436 | P02462 | |
| APSESHAGAQPRPRG | 331 | Q02833 | |
| GPPGVRSRRPSGSQH | 236 | Q9C0H5 | |
| PRGGIPPRAHSRDSS | 181 | Q8N684 | |
| IGTFRSPHGQTRPPA | 711 | Q9H8V3 | |
| QEREGPGRDHAPSIP | 606 | Q9Y4B5 | |
| SPPPGFDSVIARGHT | 461 | Q9Y6F1 | |
| VGEDSRHAGPPVLPR | 1046 | Q9P2P5 | |
| ESEASRPPRVHGPPT | 526 | Q96GW7 | |
| RPEPSETGVSHLRPE | 511 | Q5HY64 | |
| AGHEPRVPTSGTGDP | 2971 | Q8WXI7 | |
| AGHLPRGSPVTTREP | 1551 | Q9Y618 | |
| RESPGHVPSTLDAGP | 841 | Q96RG2 | |
| QLHERETPRPEGGSP | 471 | Q9BR39 | |
| PRTPSPESHRSPAEG | 636 | Q66K74 | |
| RVSSRKRHPAGPPGE | 661 | Q6P1M3 | |
| EHARSPQPRGPAEEG | 1156 | Q4ZG55 | |
| AGHSIGPSPVPSVVR | 391 | Q6PXP3 | |
| APGPHPALVEGRRSS | 501 | Q15742 | |
| PSGHVERSPEGLESP | 776 | Q76N89 | |
| TLTPAGGHLPRPEAS | 121 | A6NHT5 | |
| SLRAGPSEPHSPGRR | 86 | O00221 | |
| RPIPTPVGSVHVDSG | 331 | Q9HCP0 | |
| PRRGPSPSHVRFEDE | 441 | Q5VZ46 | |
| ASRPHAPGTPAGRVR | 806 | Q8TDD1 | |
| SPGRSPDLAPHLGRA | 1981 | Q9P219 | |
| ARGHTDTEGRPPSPP | 351 | Q00613 | |
| HPAPPATAVRGRDAA | 186 | C9JC47 | |
| PAPGAREDEHVRAPS | 71 | P15172 | |
| HPPPRQGRGSFSREE | 506 | Q8TDF6 | |
| EPGAGTPSPVRLHAL | 136 | Q63ZY6 | |
| HTRPDGAPALESPRI | 106 | O95644 | |
| RVPREPGVHTGSSRP | 736 | Q9P1Y6 | |
| GSGRSTPRRIPHSPA | 696 | Q13136 | |
| GPPRATVHRPLAATS | 81 | Q9H1U4 | |
| PSAIAAGPARTPDRH | 226 | Q96S07 | |
| SVDSAPPPGRHGRLF | 56 | Q86UT6 | |
| PTRDVPSGHTRDPAR | 3251 | O95613 | |
| AFTLGSAHTPGRPPR | 1026 | O95248 | |
| HTLAPERSVSGPLGP | 206 | P81408 | |
| EHPAPPATAVRGRDA | 186 | P0CG42 | |
| ERPAGRTQSPEHGSP | 6 | Q6TDP4 | |
| DPNGTRVRHGSGPPS | 301 | Q9HC52 | |
| PAREPSLERVGGHPT | 301 | Q96B18 | |
| HPGSPTRAAERVEPF | 21 | Q9Y6N1 | |
| GGITDPGTVPRVPSH | 786 | Q7Z3C6 | |
| RHSGVPEAPDRPTIS | 716 | Q4KMG0 | |
| TPAEGRDSPTREPGA | 526 | Q96RY5 | |
| PRAHAEVDGRSTEPP | 226 | Q8TBE0 | |
| GPPEPSRHFQVREGE | 546 | Q6ZMT9 | |
| RRVGPSSGDAPEPSS | 976 | Q86V48 | |
| PSGPHRRLGSPQAIE | 1576 | Q6P0Q8 | |
| PTPTPIRAGDGHRLT | 141 | Q8N6P7 | |
| VSGPREPAGAPQRHS | 306 | Q8N6P7 | |
| GVSHLRPEPPETGVS | 231 | Q5JRC9 | |
| ETGVSHIRPGPPITR | 241 | Q5JRC9 | |
| THERAPSPGRGVPRS | 146 | Q6NY19 | |
| RAVVHGPREGPESRP | 21 | Q9Y2Y9 | |
| AGAVVHRRPPDPEGA | 21 | Q8TD94 | |
| REGSRLPPAREGHPV | 71 | O95817 | |
| PGTLRRVPVPTSHSG | 21 | Q9BUN5 | |
| SPGRGPPDAESVHSI | 561 | O95180 | |
| GPPLGPSHRDTISRS | 1396 | Q5VT52 | |
| GPRDPSSLEAHGPRS | 196 | O43304 | |
| RIGDGSPSHPPILER | 1281 | Q58EX2 | |
| PGSARVEPHSPLRGG | 2021 | Q8TDX9 | |
| PPHSEGRSEFPSGLI | 1381 | Q96PC5 | |
| HRAPQPGPSRSEKTG | 1161 | Q9NZ71 | |
| RPASTSPSPGAHGRR | 466 | A6NNA2 | |
| AERHGGSPQPLATTP | 371 | Q9UQ35 | |
| RSEFGSVDGPLPHPR | 1701 | Q5JRA6 | |
| QTPPERHDSGGSLPL | 31 | Q96MH2 | |
| SHPEPQLPGLRESSG | 216 | Q5JXC2 | |
| RPERPVGPLTHTRGD | 421 | Q96B97 | |
| PGVHPSGLVPRERSD | 746 | P48634 | |
| TDRGTEPGPIRPSHR | 1741 | P48634 | |
| GFPPRPAHGDVSVTD | 291 | Q6UXD5 | |
| TTRSPGSPPTLRVHG | 966 | A1L4H1 | |
| VPGTTDGHRPTAEAP | 306 | P40967 | |
| SSRGPGRPVSSPHEL | 461 | Q68D10 | |
| PRARTVSVSVPPHGG | 1841 | Q99466 | |
| ASPGDSATGHRRPPL | 651 | Q14162 | |
| RTHPTVPGIPGGTRA | 476 | O00327 | |
| RATSRPGFPPLEGSH | 126 | Q8NCQ2 | |
| PGPSSPAGGEDRVHV | 51 | Q9GZS9 | |
| HHDGVLRPTVRPGTP | 76 | O95476 | |
| TPRRGPESLPVGHHD | 1316 | Q99570 | |
| PGPGEPTLRSRQDRH | 166 | Q6S5L8 | |
| ETGGHRRSFPPRTNP | 291 | Q9Y2H5 | |
| AAPTGPGHRALPSRD | 61 | Q8NHY6 | |
| RPPSHGGPTRDLQSS | 321 | Q9UN79 | |
| RGPRPVARGPAHSSS | 66 | P0C879 | |
| ERGPSHSRASLVIPP | 306 | Q8N2C7 | |
| RIPSPGTHPEGEAAQ | 306 | Q9H171 | |
| GAAAGPRTPSAHIPV | 76 | Q9NR83 | |
| PGGGSFAREPSPTHR | 976 | Q9BYB0 | |
| RSPTPVHSPDADRPG | 1126 | Q9BYB0 | |
| PRRPQPGASGRSTHT | 811 | O95428 | |
| PGHERRGTPADTEEP | 46 | Q9BQI7 | |
| GKRHGPVPVEARTAP | 3336 | P22105 | |
| RHRTVGTNTPPSPGF | 1181 | Q9HBL0 | |
| RHAAERPGGTPTPVI | 786 | Q9P1Z0 | |
| SGRHRLGPSPEPAAS | 26 | Q86WS5 | |
| QRPAHRPGPATSSSG | 181 | O60504 | |
| TPARLPSGHAPGQDR | 261 | Q9Y6S9 | |
| PPRAKTDHGVPSGAR | 426 | A6NDV4 | |
| SPRVSGEEELHTGPP | 726 | Q9UPN7 | |
| PPKRGTAVHGAEPAE | 3876 | Q96JG9 | |
| PDTPRPHRGLGATRE | 861 | Q9ULT6 | |
| LRSEGGPPTPHRSIF | 451 | Q9ULC8 | |
| AHVPAATPLPERGGS | 1206 | Q9H7P9 | |
| SRGSGRHSSPAPAQP | 1081 | Q70CQ4 | |
| PVSSDSGDEGPRARP | 1841 | Q9Y3S1 | |
| PVRSSARAEHGAEPP | 31 | Q5H8A4 | |
| PDSTHPRGPIGLVVR | 516 | Q96PF1 | |
| REGPSGHSTLPRSPR | 881 | Q63HR2 | |
| EIHASLVPGPSERPG | 231 | P30518 | |
| QVLRPEGDRHSPPGT | 886 | Q9H0D2 | |
| HIERRVSNAGGPPAP | 151 | P50552 | |
| HGVEPGTSRRPPDTA | 151 | Q8NCA9 |